POULTON STUART (EVP, Chief Development Officer) sold 0.4% of their position (403.00 shares) of KARYOPHARM THERAPEUTICS INC. on the open market
Open‑market sale worth $3.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/15/2026ACC: 0001193125-26-226697
Officer· EVP, Chief Development Officer
Since Mar 2026
+493.00
Net shares
Net buyer
$3.8K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
896.00 acquired · 403.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+896.00
Price / share
—
Trade value
—
% of position
0.9%
5/13/2026
94.33K→95.22K
Common Stock
Direct
Shares
−403.00
Price / share
$9.50
Trade value
$3.83K
% of position
0.4%
5/14/2026
95.22K→94.82K
Total
Net shares
+493.00
Net value
-$3.83K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/13/2026 | A · Award | +896.00 | — | — | 0.9% | 94.33K | 95.22K |
| Common Stock Direct | 5/14/2026 | S · Sale | −403.00 | $9.50 | $3.83K | 0.4% | 95.22K | 94.82K |
| Total | +493.00 | -$3.83K | ||||||
Derivative Transactions0
No derivative transactions reported